Nano-X Imaging (NNOX) and Its Rivals Head-To-Head Survey

Nano-X Imaging (NASDAQ:NNOX – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Nano-X Imaging to similar companies based on the strength of its profitability, dividends, earnings, valuation, analyst recommendations, risk and institutional ownership.

Volatility and Risk

Nano-X Imaging has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Nano-X Imaging’s competitors have a beta of 2.58, meaning that their average share price is 158% more volatile than the S&P 500.

Valuation and Earnings

This table compares Nano-X Imaging and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Nano-X Imaging $13.02 million -$75.02 million -0.13
Nano-X Imaging Competitors $1.87 billion $136.27 million 5.71

Nano-X Imaging’s competitors have higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 15.0% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Nano-X Imaging and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nano-X Imaging -926.05% -116.93% -100.67%
Nano-X Imaging Competitors -269.88% -187.36% -21.77%

Analyst Recommendations

This is a summary of recent ratings and target prices for Nano-X Imaging and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging 1 2 2 1 2.50
Nano-X Imaging Competitors 4314 10603 18404 838 2.46

Nano-X Imaging currently has a consensus target price of $4.33, indicating a potential upside of 1,407.25%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 23.56%. Given Nano-X Imaging’s stronger consensus rating and higher probable upside, research analysts plainly believe Nano-X Imaging is more favorable than its competitors.

Summary

Nano-X Imaging competitors beat Nano-X Imaging on 9 of the 13 factors compared.

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. is an Israeli medical technology company developing digital X-ray imaging systems and related services. Its Nanox.ARC system is designed to produce medical images using the company’s digital X-ray technology, with the goal of expanding access to diagnostic imaging. The company’s broader offering includes Nanox.CLOUD, a cloud-based platform intended to connect imaging systems with image-management and diagnostic services, and Nanox.AI, which develops artificial-intelligence tools for analyzing medical images.

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.